Michael Carusi

Mr. Carusi joined Advanced Technology Ventures (ATV) in 1998, where he focused on investments in the life sciences and medical device sectors. In addition to EndoGastric Solutions, Mr. Carusi currently serves on the boards of several ATV portfolio companies including Emphasys Medical, GI Dynamics, GluMetrics, Plexxikon, TranS1, and XTENT.

Prior to joining ATV, Mr. Carusi served as the Director of Business Development for Inhale Therapeutic Systems (now Nektar Therapeutics), a venture-backed pulmonary drug delivery company that went public in 1994. At Inhale, he lead partnering activities with a number of well-established pharmaceutical and biotechnology companies in the U.S., Europe, and Japan. Mr. Carusi was also a Principal at The Wilkerson Group, a strategic ATV partner and leading management consulting firm focused exclusively on healthcare. At The Wilkerson Group, he helped establish the firm’s offices in London and San Francisco.